logo-loader
viewMagicMed Industries Inc

MagicMed Industries signs deal with U of Calgary to accelerate Psybrary development

MagicMed Industries CEO Dr. Joseph Tucker and Dr. Stephen Larter, Professor, University of Calgary joined Steve Darling from Proactive with news MagicMed has entered into a Research Contract and a Facilities Use Agreement with the University of Calgary. Tucker telling Proactive this allows MagicMed to tap into facility and laboratory support to try and accelerate the development of its psychedelic derivatives patent library, the Psybrary. Meanwhile, Dr. Larter discusses why the University thought this would be a good partnership moving forward.

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MagicMed Industries Inc named herein, including the promotion by the Company of MagicMed Industries Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

MagicMed completes patent portfolio of their Psybrary while launching...

MagicMed Industries CEO Dr. Joseph Tucker joined Steve Darling from Proactive with news the company completed the development of their psilocybin-derivatives patent portfolio which they call “The Psybrary” Tucker says the Psybrary is a collection of novel psychedelic-derivative drug...

3 weeks, 5 days ago

2 min read